Literature DB >> 33484701

SMOC1 and IL-4 and IL-13 Cytokines Interfere with Ca2+ Mobilization in Primary Human Keratinocytes.

Taras Lyubchenko1, Hannah K Collins1, Kathryn A Vang2, Donald Y M Leung3, Elena Goleva4.   

Abstract

Immunoregulatory effects of IL-4 and IL-13 and alterations of keratinocyte (KC) differentiation are important factors in the pathogenesis of atopic dermatitis. This study investigated the role of IL-4 and IL-13 in KC responses to changes in extracellular calcium (Ca2+) and analyzed differentiation signals elicited via a Ca2+ sensor, SMOC1. Real-time dynamics of transmembrane Ca2+ influx were assessed in live KCs by flow cytometry and microscopy. Exposure of KCs to a high Ca2+ environment (1.3 mM) triggered a rapid intracellular Ca2+ influx, whereas IL-4- and IL-13-treated cells exhibited a significant decrease in the peak amplitude of Ca2+ influx (P < 0.01). IL-17A and IL-22 did not elicit such responses. Evaluation of intracellular Ca2+ dynamics by microscopy confirmed these observations and revealed heterogeneity of individual KC responses. IL-4 and IL-13 significantly inhibited the expression of Ca2+-binding protein SMOC1 (P < 0.001). Inhibition of epidermal differentiation markers were also observed in SMOC1 small interfering RNA-transfected KCs. Concurrently, the deletion of SMOC1 increased the amplitude of Ca2+ peak response (P < 0.05). In conclusion, our results provide innovative data that IL-4 and IL-13 regulate KC sensitivity to microenvironmental Ca2+ changes and inhibit Ca2+-induced KC differentiation signals. SMOC1 inhibition by IL-4 and IL-13 alters Ca2+ transport in KCs and inhibits differentiation, suggesting a new target for treatment of atopic dermatitis.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33484701      PMCID: PMC9141376          DOI: 10.1016/j.jid.2020.12.026

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   7.590


  49 in total

1.  Expression of keratin 1, keratin 10, desmoglein 1 and desmocollin 1 in the epidermis: possible downregulation by interleukin-4 and interleukin-13 in atopic dermatitis.

Authors:  Ami Totsuka; Miyuki Omori-Miyake; Makoto Kawashima; Junji Yagi; Yuichiro Tsunemi
Journal:  Eur J Dermatol       Date:  2017-06-01       Impact factor: 3.328

Review 2.  Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.

Authors:  Jacques Simard; Marie-Louise Ricketts; Sébastien Gingras; Penny Soucy; F Alex Feltus; Michael H Melner
Journal:  Endocr Rev       Date:  2005-01-04       Impact factor: 19.871

3.  Location and phenotype of human adult keratinocyte stem cells of the skin.

Authors:  Angela Webb; Amy Li; Pritinder Kaur
Journal:  Differentiation       Date:  2004-10       Impact factor: 3.880

4.  In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans.

Authors:  Miyuki Omori-Miyake; Masakatsu Yamashita; Yuichiro Tsunemi; Makoto Kawashima; Junji Yagi
Journal:  J Invest Dermatol       Date:  2013-11-26       Impact factor: 8.551

5.  Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.

Authors:  Ichiro Nomura; Elena Goleva; Michael D Howell; Quatyba A Hamid; Peck Y Ong; Clifton F Hall; Marc A Darst; Bifeng Gao; Mark Boguniewicz; Jeffrey B Travers; Donald Y M Leung
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

Review 6.  Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications.

Authors:  Tali Czarnowicki; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol Pract       Date:  2014-04-25

7.  Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

Authors:  Lisa A Beck; Diamant Thaçi; Jennifer D Hamilton; Neil M Graham; Thomas Bieber; Ross Rocklin; Jeffrey E Ming; Haobo Ren; Richard Kao; Eric Simpson; Marius Ardeleanu; Steven P Weinstein; Gianluca Pirozzi; Emma Guttman-Yassky; Mayte Suárez-Fariñas; Melissa D Hager; Neil Stahl; George D Yancopoulos; Allen R Radin
Journal:  N Engl J Med       Date:  2014-07-10       Impact factor: 91.245

8.  Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.

Authors:  Julia K Gittler; Avner Shemer; Mayte Suárez-Fariñas; Judilyn Fuentes-Duculan; Kara J Gulewicz; Claire Q F Wang; Hiroshi Mitsui; Irma Cardinale; Cristina de Guzman Strong; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2012-08-27       Impact factor: 10.793

9.  SERPINB3/B4 contributes to early inflammation and barrier dysfunction in an experimental murine model of atopic dermatitis.

Authors:  Umasundari Sivaprasad; Kayla G Kinker; Mark B Ericksen; Mark Lindsey; Aaron M Gibson; Stacey A Bass; Nicolas S Hershey; Jingyuan Deng; Mario Medvedovic; Gurjit K Khurana Hershey
Journal:  J Invest Dermatol       Date:  2014-08-11       Impact factor: 8.551

10.  SMOC1 silencing suppresses the angiotensin II-induced myocardial fibrosis of mouse myocardial fibroblasts via affecting the BMP2/Smad pathway.

Authors:  Yize Wang; Xianming Wu
Journal:  Oncol Lett       Date:  2018-06-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.